Wells Fargo upgraded Pulmonx shares to overweight on Monday, noting that the company is gaining traction after weathering Covid headwinds.
You are here: Home / Shares of new emphysema treatment maker could rally more than 40%, says Wells Fargo
Market News and Views
Wells Fargo upgraded Pulmonx shares to overweight on Monday, noting that the company is gaining traction after weathering Covid headwinds.